Clinical Trial Update: Long-term Follow-up of Phase 1 Clinical Trial of CS10BR05(CS10BR05-MSA101)

View source ↗

Summary

This note reports long-term follow-up results from a Phase 1 trial of CS10BR05 (MSA101) in patients with Multiple System Atrophy, completed by Corestemchemon, I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• CS10BR05 (MSA101)

Snippet

Sponsor: Corestemchemon, Inc. | Conditions: Multiple System Atrophy | Status: COMPLETED